A 41-year-old male with bipolar I depression is started on lurasidone 40 mg daily. At his 4-week follow-up, he reports minimal improvement in depressive symptoms despite good adherence. Upon detailed medication reconciliation, the PMHNP discovers he has been taking lurasidone on an empty stomach each morning before leaving for work. Which of the following best explains the likely reason for his subtherapeutic response?